APOA1 and Alzheimer disease: Compared to age-matched cognitively healthy controls, levels of cerebrospinal fluid (CSF) apoA-I increase during aging but are significantly lower in AD and mild cognitive impairment patients compared to age-matched cognitively normal controls[176].